Last update :
06/05/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Neuroleptic   Haloperidol lactate  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Aloperidin Greece
Aloperidolo Italy
Haldol Australia, Austria, Belgium, Chile, Denmark, Ecuador, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Japan, Luxembourg, Malaysia, Mexico, Morocco, Norway, Poland, Sweden, Switzerland, Tunisia, Venezuela
Halodic Iran
Halonace Egypt
Haloperidol Colombia, Ecuador, Egypt, Great Britain, Hungary, Iran, Peru, Portugal
Halopidol Argentina, Colombia
Haloprol Egypt
Manace Malaysia
Norodol Turkey
Serenace Australia, Great Britain, Ireland, New Zealand
Serenase Italy
Serenelfi Portugal
Sylador Saudi Arabia
Stability of mixtures   Injection   Stability of mixtures : Haloperidol lactate     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Polyvinyl chloride Sodium chloride 0,9% 52 mg/ml
Injection   Haloperidol lactate   
Injection   Glycopyrronium bromide 15 mg/ml
Injection   Buprenorphine hydrochloride 57 mg/ml
21°C
30 Day
Protect from light 2113
Level of evidence D
Polyvinyl chloride Sodium chloride 0,9% 52 mg/ml
Injection   Haloperidol lactate   
Injection   Glycopyrronium bromide 15 mg/ml
Injection   Buprenorphine hydrochloride 57 mg/ml
36°C
9 Day
Protect from light 2113
Level of evidence D
Polyvinyl chloride Sodium chloride 0,9% 0.02 >> 0.2 mg/ml
Injection   Haloperidol lactate   
Injection   Morphine hydrochloride 0.2 >> 18  mg/ml
37°C
7 Day
Not specified 2362
Polyvinyl chloride Sodium chloride 0,9% 52 mg/ml
Injection   Haloperidol lactate   
Injection   Glycopyrronium bromide 15 mg/ml
Injection   Buprenorphine hydrochloride 57 mg/ml
4°C
30 Day
Protect from light 2113
Level of evidence D
Polypropylene Sodium chloride 0,9% 52 mg/ml
Injection   Haloperidol lactate   
Injection   Glycopyrronium bromide 15 mg/ml
Injection   Buprenorphine hydrochloride 57 mg/ml
21°C
30 Day
Protect from light 2113
Level of evidence D
Polypropylene Sodium chloride 0,9% 0,42 & 0,62 mg/ml
Injection   Haloperidol lactate   
Injection   Scopolamine N-butyl bromide 5 & 6,67 mg/ml
Injection   Morphine hydrochloride 1,67>> 10 mg/ml
25°C
15 Day
Protect from light 2055
Level of evidence B+
Polypropylene Sodium chloride 0,9% 0,208 mg/ml
Injection   Haloperidol lactate   
Injection   Tramadol hydrochloride 8,33 mg/ml
25°C
15 Day
Protect from light 2024
Level of evidence C+
Polypropylene Sodium chloride 0,9% 0,625 mg/ml
Injection   Haloperidol lactate   
Injection   Tramadol hydrochloride 33,33 mg/ml
25°C
15 Day
Protect from light 2024
Level of evidence C+
Polypropylene Sodium chloride 0,9% 52 mg/ml
Injection   Haloperidol lactate   
Injection   Glycopyrronium bromide 15 mg/ml
Injection   Buprenorphine hydrochloride 57 mg/ml
36°C
16 Day
Protect from light 2113
Level of evidence D
Polypropylene Sodium chloride 0,9% 0,312 mg/ml
Injection   Haloperidol lactate   
Injection   Scopolamine N-butyl bromide 2,5 & 5 & 10 mg/ml
4°C
15 Day
Protect from light 1970
Polypropylene Sodium chloride 0,9% 0,208 mg/ml
Injection   Haloperidol lactate   
Injection   Tramadol hydrochloride 8,33 mg/ml
4°C
15 Day
Protect from light 2024
Level of evidence C+
Polypropylene Sodium chloride 0,9% 0,625 mg/ml
Injection   Haloperidol lactate   
Injection   Tramadol hydrochloride 33,33 mg/ml
4°C
15 Day
Protect from light 2024
Level of evidence C+
Polypropylene Sodium chloride 0,9% 52 mg/ml
Injection   Haloperidol lactate   
Injection   Glycopyrronium bromide 15 mg/ml
Injection   Buprenorphine hydrochloride 57 mg/ml
4°C
30 Day
Protect from light 2113
Level of evidence D
Polyolefine NaCl 0,9% or Glucose 5% 0,05 mg/ml
Injection   Haloperidol lactate   
Injection   Dexketoprofen 2,5 mg/ml
Injection   Tramadol hydrochloride 5 mg/ml
- 20°C
30 Day
Protect from light 3297
Level of evidence C
Polyolefine NaCl 0,9% or Glucose 5% 0,05 mg/ml
Injection   Haloperidol lactate   
Injection   Dexketoprofen 2,5 mg/ml
Injection   Tramadol hydrochloride 5 mg/ml
25°C
30 Day
With or without light 3297
Level of evidence C
Polyolefine NaCl 0,9% or Glucose 5% 0,05 mg/ml
Injection   Haloperidol lactate   
Injection   Dexketoprofen 2,5 mg/ml
Injection   Tramadol hydrochloride 5 mg/ml
4°C
30 Day
Protect from light 3297
Level of evidence C
Ethylene vinyl acetate Sodium chloride 0,9% 0.02 >> 0.2 mg/ml
Injection   Haloperidol lactate   
Injection   Morphine hydrochloride 0.2 >> 18  mg/ml
2-8°C
14 Day
Protect from light 2362
Ethylene vinyl acetate Sodium chloride 0,9% 0.02 >> 0.2 mg/ml
Injection   Haloperidol lactate   
Injection   Morphine hydrochloride 0.2 >> 18  mg/ml
37°C
7 Day
Not specified 2362
Polypropylen Syringe Water for Injection 0,75 mg/ml
Injection   Haloperidol lactate   
Injection   Diamorphine hydrochloride 20 mg/ml
18-22°C
20 Day
Light 1886
Level of evidence D
Polypropylen Syringe Sodium chloride 0,9% 0,5 mg/ml
Injection   Haloperidol lactate   
Injection   Scopolamine hydrobromide 0,04 mg/ml
Injection   Famotidine 0,4 mg/ml
Injection   Dimenhydrinate 5 mg/ml
Injection   Hydromorphone hydrochloride 10 mg/ml
25°C
12 Hour
Not specified 2166
Polypropylen Syringe Sodium chloride 0,9% 0,5 mg/ml
Injection   Haloperidol lactate   
Injection   Metoclopramide hydrochloride 0,5 mg/ml
Injection   Hydromorphone hydrochloride 10 mg/ml
25°C
96 Hour
Not specified 2166
Polypropylen Syringe Sodium chloride 0,9% 0,5 mg/ml
Injection   Haloperidol lactate   
Injection   Scopolamine hydrobromide 0,04 mg/ml
Injection   Famotidine 0,4 mg/ml
Injection   Dimenhydrinate 5 mg/ml
Injection   Hydromorphone hydrochloride 10 mg/ml
4°C
12 Hour
Not specified 2166
Polypropylen Syringe None 0,31 mg/ml
Injection   Haloperidol lactate   
Injection   Diamorphine hydrochloride 6,25 & 12,5 mg/ml
22°C-24°C
24 Hour
With or without light 779
Level of evidence D
Polypropylen Syringe None 0,31 mg/ml
Injection   Haloperidol lactate   
Injection   Diamorphine hydrochloride 6,25 & 12,5 mg/ml
4-8°C
7 Day
Protect from light 779
Level of evidence D
Not specified Sodium chloride 0,9% 0,208 >> 0,624 mg/ml
Injection   Haloperidol lactate   
Injection   Scopolamine N-butyl bromide 3,33 >> 6,67 mg/ml
Injection   Tramadol hydrochloride 8,8 >> 33,3 mg/ml
25°C
15 Day
Protect from light 3132
Level of evidence C+
  Mentions Légales